InfuSystem Holdings INFU
NYSE INFU
$12.25 +0.06 (+0.50%)
At close: Aug 20, 2026 · 11:17 AM UTC

InfuSystem Holdings (INFU) Income towards Parent Company (2010 - 2026)

InfuSystem Holdings' (INFU) quarterly Income towards Parent Company came in at $1.0 million in Q1 2026, up 562.27% YoY from $153562.1 in Q1 2025, and down 50.68% on a QoQ basis from $2.1 million in Q4 2025.

InfuSystem Holdings (INFU) Income towards Parent Company (2010 - 2026) Analysis & Trends

InfuSystem Holdings (INFU) has 17 years of Income towards Parent Company data on file, last reported at $1.0 million in Q1 2026.

  • Quarterly Income towards Parent Company rose 562.27% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 147.29% YoY) and the FY2025 annual result came in at $6.6 million, up 182.6% from the prior year.
  • Income towards Parent Company slipped to $1.0 million in Q1 2026, from $2.1 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $2.6 million in Q2 2025 to a low of -$1.1 million in Q1 2024.
  • A 5-year average of $652235.3 and a median of $443000.0 in 2022 frame the typical range for Income towards Parent Company.
  • The widest YoY moves for Income towards Parent Company: up 884.38% in 2024, down 266.0% in 2024.
  • Tracing INFU's Income towards Parent Company over 5 years: stood at $138000.0 in 2022, then tumbled by 30.43% to $96000.0 in 2023, then jumped by 884.38% to $945000.0 in 2024, then surged by 118.2% to $2.1 million in 2025, then sank by 50.68% to $1.0 million in 2026.
  • The last three Income towards Parent Company figures came in at $1.0 million (Q1 2026), $2.1 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 InfuSystem Holdings 244.27 Mn 243.30 Mn 21.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.26 Mn
Mar 31, 2026 1.02 Mn
Dec 31, 2025 2.06 Mn
Sep 30, 2025 2.26 Mn
Jun 30, 2025 2.60 Mn
Mar 31, 2025 -220,000.00
Dec 31, 2024 945,000.00
Sep 30, 2024 1.79 Mn
Jun 30, 2024 700,000.00
Mar 31, 2024 -1.10 Mn
Dec 31, 2023 96,000.00
Sep 30, 2023 720,000.00
Jun 30, 2023 435,000.00
Mar 31, 2023 -300,000.00
Dec 31, 2022 138,000.00
Sep 30, 2022 443,000.00
Jun 30, 2022 -164,000.00
Mar 31, 2022 -330,000.00
Dec 31, 2021 387,000.00
Sep 30, 2021 -448,000.00